Quantbot Technologies LP Grows Position in The Clorox Company $CLX

Key Points

• Quantbot Technologies LP increased its stake in The Clorox Company by 182.9% during the first quarter, owning a total of 15,102 shares worth approximately $2.22 million.
• The Clorox Company reported $2.87 earnings per share for the last quarter, significantly exceeding the consensus estimate of $2.24, alongside a revenue increase of 4.5% year-over-year.
• Clorox announced a quarterly dividend of $1.24 per share, increasing from the previous $1.22, with a current dividend yield of 4.1%.

Quantbot Technologies LP lifted its stake in The Clorox Company (NYSE:CLX - Free Report) by 182.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,102 shares of the company's stock after purchasing an additional 9,763 shares during the period. Quantbot Technologies LP's holdings in Clorox were worth $2,224,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Wood Tarver Financial Group LLC acquired a new stake in shares of Clorox in the fourth quarter valued at about $31,000. GW&K Investment Management LLC lifted its stake in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after purchasing an additional 208 shares during the period. Roble Belko & Company Inc lifted its stake in shares of Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after purchasing an additional 211 shares during the period. Menard Financial Group LLC acquired a new stake in shares of Clorox in the fourth quarter valued at about $63,000. Finally, IMA Advisory Services Inc. acquired a new stake in shares of Clorox in the first quarter valued at about $58,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CLX. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the company an "underperform" rating in a research note on Tuesday, May 6th. Jefferies Financial Group dropped their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Wells Fargo & Company raised their target price on shares of Clorox from $135.00 to $138.00 and gave the company an "equal weight" rating in a report on Friday, August 1st. Barclays dropped their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday, July 25th. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Clorox currently has an average rating of "Reduce" and a consensus price target of $143.36.

Clorox Trading Up 0.3%

Shares of NYSE CLX traded up $0.3360 during midday trading on Friday, reaching $120.1760. 1,278,389 shares of the stock were exchanged, compared to its average volume of 1,919,885. The company has a market capitalization of $14.70 billion, a P/E ratio of 18.43, a P/E/G ratio of 0.96 and a beta of 0.49. The Clorox Company has a 52-week low of $117.35 and a 52-week high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a 50 day moving average price of $124.25 and a 200-day moving average price of $135.30.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company's quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date is Wednesday, August 13th. Clorox's payout ratio is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.